{
  "catalogId": "a69cd816-805c-42c1-8069-99cd8a9fdbac",
  "name": "BENDAMUSTINE MEDAC 100 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "163 73 35386 00",
  "treatmentDescriptions": "First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.",
  "termsOfIssue": "Prescription required",
  "form": "powder for concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "BENDAMUSTINE  HYDROCHLORIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01AA09",
      "name": "BENDAMUSTINE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "BENDAMUSTINE MEDAC 25 MG 1 VIAL",
      "manufacturer": {
        "name": "צמל",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8661",
        "yarpa": "28455",
        "pharmasoft": "2779",
        "barcode": "7290100819029"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 93.65292,
        "retailMargin": 34.5,
        "maxRetailPrice": 125.9631774,
        "maxPriceWithVAT": 148.6365493
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.888588"
  }
}